VRDN
Viridian Therapeutics, Inc.
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $26M | +132.2% |
| Gross profit | $789K2016 | — |
| Operating income | −$469M | — |
| Net income | −$454M | — |
| EPS | −$5.312023 | — |
| Free cash flow | −$343M | — |
Viridian Therapeutics, Inc.
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $26M | +132.2% |
| Gross profit | $789K2016 | — |
| Operating income | −$469M | — |
| Net income | −$454M | — |
| EPS | −$5.312023 | — |
| Free cash flow | −$343M | — |